| Members |
targetComponentId |
| Monocytic leukemia in remission |
Myeloid leukemia in remission |
| Monocytoid B-cell lymphoma |
Marginal zone B-cell lymphoma |
| Monooxygenase |
Monooxygenase |
| Scedosporium apiospermum |
Scedosporium boydii |
| misfoster, ikke nærmere specificeret |
Congenital malformation |
| Misfoster med kranieanomalier |
Congenital anomaly of skull |
| Monstrocellular sarcoma |
Giant cell glioblastoma |
| Montelukast sodium 4mg oral granules |
Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 sachet conventional release oral granules (clinical drug) |
| "Monterey fluency program" til vurdering af talefærdighed |
Monterey Fluency Program (regime/therapy) |
| alkoholfremkaldt affektiv sindslidelse |
Mood disorder caused by ethanol (disorder) |
| Mood disorder with depressive symptoms caused by alcohol |
Mood disorder with depressive symptoms caused by ethanol |
| Mood disorder with manic symptoms caused by alcohol |
Mood disorder with manic symptoms caused by ethanol (disorder) |
| Mood disorder with mixed manic and depressive symptoms caused by alcohol |
Mood disorder with mixed manic and depressive symptoms caused by ethanol |
| Moraxella (Moraxella) phenylpyruvica |
Psychrobacter phenylpyruvicus |
| Moraxella anatipestifer |
Riemerella anatipestifer |
| More supplement & complete foods [1] |
Nutritional supplement (substance) |
| More supplement & complete foods [3] |
Nutritional supplement (substance) |
| hostehæmmende morphinanmiddel |
Morphinan opioid |
| bivirkning af hostehæmmende morphinanmiddel |
Morphinan opioid adverse reaction |
| allergi over for hostehæmmende middel indeholdende morphinan |
Allergy to morphinan opioid |
| ikke-farmaceutisk morphin |
Morphine (substance) |
| morphinhydrochlorid 10 mg/ml oral opløsning |
Product containing precisely morphine sulfate 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Morphine sulfate 100mg + naltrexone hydrochloride 4mg m/r capsule |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| Morphine sulfate 100mg + naltrexone hydrochloride 4mg prolonged-release oral capsule |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| morphinsulfat 100 mg rektaltampon |
Morphine sulfate 100 mg rectal suppository |
| morphinsulfat 100 mg brev granulat til suspension |
Product containing precisely morphine sulfate 5 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| morphinsulfat 10 mg/ml liposom depotinjektion |
Morphine sulfate liposome 10 mg/mL solution for injection |
| morphinsulfat 200 mg brev granulat til suspension |
Product containing precisely morphine sulfate 6.67 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Morphine sulfate 20mg + naltrexone hydrochloride 800microgram m/r capsule |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| Morphine sulfate 20mg + naltrexone hydrochloride 800microgram prolonged-release oral capsule |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| morphinsulfat 20 mg brev granulat til suspension |
Product containing precisely morphine sulfate 2 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Morphine sulfate 30mg + naltrexone hydrochloride 1.2mg m/r capsule |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| Morphine sulfate 30mg + naltrexone hydrochloride 1.2mg prolonged-release oral capsule |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| morfinsulfat 30 mg/5 ml oral enhedsdosis, hætteglas |
Product containing precisely morphine sulfate 6 milligram/1 milliliter conventional release oral solution (clinical drug) |
| morphinsulfat 30 mg brev granulat til suspension |
Morphine sulfate 3 mg/mL oral suspension |
| morphinsulfat 35 mg rektaltampon |
Morphine sulfate 35 mg rectal suppository |
| Morphine sulfate 50mg + naltrexone hydrochloride 2mg m/r capsule |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| Morphine sulfate 50mg + naltrexone hydrochloride 2mg prolonged-release oral capsule |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| morphinsulfat 50 mg rektaltampon |
Morphine sulfate 50 mg rectal suppository |
| Morphine sulfate 60mg + naltrexone hydrochloride 2.4mg m/r capsule |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| Morphine sulfate 60mg + naltrexone hydrochloride 2.4mg prolonged-release oral capsule |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| morphinsulfat 60 mg brev granulat til suspension |
Product containing precisely morphine sulfate 6 milligram/1 milliliter conventional release oral solution (clinical drug) |
| morphinsulfat 75 mg rektaltampon |
Morphine sulfate 75 mg rectal suppository |
| Morphine sulfate 80mg + naltrexone hydrochloride 3.2mg m/r capsule |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| Morphine sulfate 80mg + naltrexone hydrochloride 3.2mg prolonged-release oral capsule |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| morphinsulfat 80 mg kapsel med modificeret udløsning |
Product containing only morphine in oral dose form (medicinal product form) |
| Morphine sulfate 80mg prolonged-release oral capsule |
Product containing only morphine in oral dose form (medicinal product form) |
| Morphine tartrate+cyclizine |
Product containing cyclizine and morphine (medicinal product) |
| Morphinian antitussive agent |
Morphinan opioid |
| Mosquito-borne bunyavirus encephalitis |
Mosquito-borne orthobunyavirus encephalitis |
| Mosquito-borne bunyavirus fever |
Mosquito-borne orthobunyavirus fever |
| Mother currently breast-feeding |
Mother currently breastfeeding |
| Mother currently breast-feeding |
Mother currently breastfeeding |
| patients mor |
Mother |
| motilitetsstimulerende middel |
Motility stimulant (substance) |
| Mould mix RAST test |
Fungal mix specific IgE antibody measurement |
| Mould mix RAST test |
Fungal mix specific IgE antibody measurement |
| Mouse mammary tumor virus |
Mouse mammary tumor virus |
| Mouse mix RAST test |
Mouse epithelium, serum proteins and urine proteins specific IgE antibody measurement |
| Mouse mix RAST test |
Mouse epithelium, serum proteins and urine proteins specific IgE antibody measurement |
| museblanding-rasttest |
Mouse epithelium, serum proteins and urine proteins specific IgE antibody measurement |
| Mouth symptom NOS |
Mouth symptoms (finding) |
| Mouth symptom NOS |
Mouth symptoms (finding) |
| Moved elsewhere |
Moved elsewhere |
| Movement measurement NEC |
Assessment of body movement (procedure) |
| Movement measurement NEC |
Assessment of body movement (procedure) |
| Moxifloxacin hydrochloride |
Product containing moxifloxacin (medicinal product) |
| moxifloxacinhydrochlorid 0,5 % opløsning til oftalmisk anvendelse |
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
| moxifloxacinhydrochlorid 1,6 mg/ml infusionsvæske, opløsning, pose a 250 ml |
Moxifloxacin (as moxifloxacin hydrochloride) 1.6 mg/mL solution for injection |
| Mucinous cystadenoma, borderline malignancy |
Mucinous cystic tumor of borderline malignancy |
| mukøs cystisk tumor med moderat dysplasi |
Mucinous cystadenoma |
| Mucoid otitis media |
Chronic mucoid otitis media |
| bivirkning af mukolytika |
All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). |
| Mucosal-associated lymphoid tissue (MALT) lymphoma |
Marginal zone B-cell lymphoma |
| Mukosit efter kemoterapi |
Inflammation of mucous membrane due to and following chemotherapy |
| antiinfektiøst middel til slimhinder |
Anti-infective agent (substance) |
| Antibiotikum til slimhinder |
Antibacterial |
| svampemiddel til slimhinder |
Antifungal |
| antiviralt slimhindemiddel |
Substance with antiviral mechanism of action (substance) |
| Mulberry molar |
Moon's molar teeth |
| Mullet - dietary |
Mullet (substance) |
| Multiceps |
Taenia |
| Multiceps |
Taenia |
| Multiceps brauni |
Taenia brauni |
| Multiceps serialis |
Taenia serialis |
| Polycystisk nyresygdom |
A rare congenital anomaly of the kidney and urinary tract (CAKUT) in which one or both kidneys (unilateral or bilateral MCDK respectively) are large, distended by multiple cysts, and non-functional. Unilateral MCDK is typically asymptomatic if the other kidney is fully functional but may occasionally present with abdominal obstructive signs when the cysts become too large. Bilateral MCDK is considered a lethal entity and neonates present with features of the Potter sequence, severe pulmonary hypoplasia and severe renal failure, and generally die shortly after birth. |
| multipel V-Y-plastik |
Reconstruction of skin using local V-Y advancement flap (procedure) |
| Lukkede multiple frakturer i kraniet OG/ELLER ansigtet med cerebral laceration OG/ELLER kontusion |
Traumatic brain injury |
| Multiple closed fractures of skull and face with intracranial injury of other and unspecified nature |
Injury of head |
| Multiple closed fractures of skull and face with other and unspecified intracranial hemorrhage |
Injury of head |
| multiple komplikationer forårsaget af diabetes mellitus |
Complication due to diabetes mellitus (disorder) |
| diabetes mellitus betinget af fejlernæing, med multiple komplikationer |
Disorder due to malnutrition related diabetes mellitus |
| multiple komplikationer ifm. type 1-diabetes mellitus |
Disorder due to type 1 diabetes mellitus |
| type 2-diabetes mellitus med multiple komplikationer |
Disorder due to type 2 diabetes mellitus (disorder) |
| multiple komplikationer ifm. type 2-diabetes mellitus |
Disorder due to type 2 diabetes mellitus (disorder) |
| multiple kongenitte anomalier, ikke nærmere specificeret |
Congenital malformation syndrome (disorder) |
| Multiple congenital anomalies NOS |
Congenital malformation syndrome (disorder) |
| Multipel kongenit ledstivhed |
A rare sporadic arthrogryposis syndrome with characteristics of multiple congenital contractures presenting in a very specific pattern. It is typically symmetric, involving all four limbs, with internally rotated shoulders, fully extended and fixed elbows, the wrists fixed in flexion, partially flexed fingers, hips fixed in flexion or extension, adducted or abducted and sometimes dislocated. The knees may be fixed in extension or flexion and the feet are usually in severe equinovarus position. The jaw and trunk are relatively spared. Normal limb muscle tissue is replaced by fatty, fibrous tissue. |
| allergi over for infusionsvæske indeholdende flere elektrolytter |
Allergy to drug |
| Multiple endocrine deficiency syndrome, NEC |
Multiple endocrine deficiency syndrome |
| Multiple ekstreme læsioner i abdominalorganer med åbent sår ind til bughulen |
Severe crushing injury of abdominal organs with open wound into cavity |
FHIR